Epidemiology Surveillance Program
Lebanese Ministry of Public Health
as on 18/07/2018
| Age group | Gender, N, 2015 | Gender, %, 2015 | ||||||
|---|---|---|---|---|---|---|---|---|
| M | F | U | T | M | F | U | T | |
| 0-4y | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 5-9y | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 10-14y | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 15-19y | 4 | 0 | 0 | 4 | 0.7 | 0.0 | 0.0 | 0.4 |
| 20-24y | 3 | 1 | 0 | 4 | 0.5 | 0.2 | 0.0 | 0.4 |
| 25-29y | 8 | 7 | 0 | 15 | 1.3 | 1.4 | 0.0 | 1.3 |
| 30-34y | 7 | 6 | 0 | 13 | 1.1 | 1.2 | 0.0 | 1.2 |
| 35-39y | 17 | 15 | 0 | 32 | 2.8 | 2.9 | 0.0 | 2.8 |
| 40-44y | 21 | 29 | 0 | 50 | 3.4 | 5.6 | 0.0 | 4.4 |
| 45-49y | 36 | 48 | 0 | 84 | 5.9 | 9.3 | 0.0 | 7.4 |
| 50-54y | 58 | 67 | 0 | 125 | 9.4 | 13.0 | 0.0 | 11.1 |
| 55-59y | 55 | 49 | 0 | 104 | 8.9 | 9.5 | 0.0 | 9.2 |
| 60-64y | 81 | 48 | 0 | 129 | 13.2 | 9.3 | 0.0 | 11.4 |
| 65-69y | 68 | 51 | 0 | 119 | 11.1 | 9.9 | 0.0 | 10.5 |
| 70-74y | 81 | 51 | 0 | 132 | 13.2 | 9.9 | 0.0 | 11.7 |
| 75+y | 153 | 129 | 0 | 282 | 24.9 | 25.1 | 0.0 | 25.0 |
| Unsp. | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total | 615 | 514 | 0 | 1129 | 100.0 | 100.0 | 0.0 | 100.0 |
|
LNCR Application Epidemiology Surveillance Program Lebanese Ministry of Public Health |
|
as on 18/07/2018
| Subsite | Gender, N, 2015 | Gender, %, 2015 | ||||||
|---|---|---|---|---|---|---|---|---|
| M | F | U | T | M | F | U | T | |
| Cecum | 16 | 11 | 0 | 27 | 2.6 | 2.1 | 0.0 | 2.4 |
| Appendix | 3 | 8 | 0 | 11 | 0.5 | 1.6 | 0.0 | 1.0 |
| Ascending colon | 49 | 46 | 0 | 95 | 8.0 | 8.9 | 0.0 | 8.4 |
| Hepatic flexure of colon | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Transverse colon | 14 | 8 | 0 | 22 | 2.3 | 1.6 | 0.0 | 1.9 |
| Splenic flexure of colon | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Descending colon | 20 | 30 | 0 | 50 | 3.3 | 5.8 | 0.0 | 4.4 |
| Sigmoid colon | 69 | 48 | 0 | 117 | 11.2 | 9.3 | 0.0 | 10.4 |
| Overlapping lesion of colon | 9 | 5 | 0 | 14 | 1.5 | 1.0 | 0.0 | 1.2 |
| Colon NOS | 252 | 217 | 0 | 469 | 41.0 | 42.2 | 0.0 | 41.5 |
| Rectosigmoid junction | 77 | 63 | 0 | 140 | 12.5 | 12.3 | 0.0 | 12.4 |
| Rectum NOS | 106 | 78 | 0 | 184 | 17.2 | 15.2 | 0.0 | 16.3 |
| Total | 615 | 514 | 0 | 1129 | 100.0 | 100.0 | 0.0 | 100.0 |
|
LNCR Application Epidemiology Surveillance Program Lebanese Ministry of Public Health |
|
as on 18/07/2018
| Group | Sub-Group | N, 2015 | %, 2015 |
|---|---|---|---|
| EPIDERMOID CARCINOMAS | SQUAMOUS CELL CARCINOMAS | 3 | 0.3 |
| EPIDERMOID CARCINOMAS | OTHER EPIDERMOID CARCINOMAS | 1 | 0.1 |
| ADENOCARCINOMAS | ADENOCARCINOMAS NOS | 957 | 84.8 |
| ADENOCARCINOMAS | ADENOCARCINOMAS IN ADENOMATOUS POLYP | 0 | 0.0 |
| ADENOCARCINOMAS | ADENOCARCINOMAS IN VILLOUS ADENOMAS | 0 | 0.0 |
| ADENOCARCINOMAS | MUCINOUS ADENOCARCINOMAS | 23 | 2.0 |
| ADENOCARCINOMAS | MUCIN PRODUCING ADENOCARCINOMAS | 0 | 0.0 |
| ADENOCARCINOMAS | SIGNET RING ADENOCARCINOMAS | 6 | 0.5 |
| ADENOCARCINOMAS | OTHER ADENOCARCINOMAS | 3 | 0.3 |
| OTHER CARCINOMAS | NEUROENDOCRINE CARCINOID | 4 | 0.4 |
| OTHER CARCINOMAS | OTHER SPECIFIC CARCINOMAS | 13 | 1.2 |
| OTHER CARCINOMAS | UNSPECIFIED CARCINOMAS NOS | 15 | 1.3 |
| SARCOMAS AND OTHER SOFT TISSUE TUMOURS | SARCOMAS AND OTHER SOFT TISSUE TUMOURS | 1 | 0.1 |
| OTHER SPECIFIED TYPES | OTHER SPECIFIC TYPES | 3 | 0.3 |
| UNSPECIFIED | UNSPECIFIED | 99 | 8.8 |
| Total | 1129 | 100.0 | |
|
LNCR Application Epidemiology Surveillance Program Lebanese Ministry of Public Health |
|
as on 18/07/2018
| Age group | Year 2015 | ||
|---|---|---|---|
| Male | Female | Both | |
| 0-4y | 0.0 | 0.0 | 0.0 |
| 5-9y | 0.0 | 0.0 | 0.0 |
| 10-14y | 0.0 | 0.0 | 0.0 |
| 15-19y | 1.4 | 0.0 | 0.7 |
| 20-24y | 1.2 | 0.4 | 0.7 |
| 25-29y | 3.3 | 2.6 | 2.9 |
| 30-34y | 3.1 | 2.4 | 2.7 |
| 35-39y | 9.6 | 7.8 | 8.7 |
| 40-44y | 14.8 | 18.9 | 16.9 |
| 45-49y | 31.5 | 39.5 | 35.6 |
| 50-54y | 57.1 | 63.4 | 60.3 |
| 55-59y | 60.3 | 50.0 | 55.0 |
| 60-64y | 97.3 | 55.6 | 76.1 |
| 65-69y | 125.2 | 83.7 | 103.3 |
| 70-74y | 171.3 | 102.2 | 135.8 |
| 75+y | 241.3 | 213.9 | 228.0 |
| Crude Rate | 20.6 | 17.1 | 18.8 |
| Crude Rate CI INF | 18.9 | 15.6 | 17.7 |
| Crude Rate CI SUP | 22.2 | 18.5 | 19.9 |
| ASR | 25.2 | 20.6 | 22.9 |
| ASR CI INF | 23.1 | 18.8 | 21.5 |
| ASR CI SUP | 27.3 | 22.4 | 24.3 |
|
LNCR Application Epidemiology Surveillance Program Lebanese Ministry of Public Health |
|